What to know
- The comparison matters: usual eating and an active weight-loss diet are different control groups.
- Most evidence does not show a substantial weight-loss advantage over continuous calorie restriction.
- Long-term adherence and safety remain important uncertainties; fasting can be risky with some diabetes medicines.
01
Does intermittent fasting work better?
For adults with overweight or obesity, intermittent fasting is an option for organizing eating, but the evidence does not establish it as a generally superior weight-loss strategy. Both fasting and continuous calorie restriction can reduce weight compared with unrestricted eating. When the comparison is another active weight-loss diet, the average difference is usually small or uncertain.
The useful question is whether restricting eating times adds enough benefit to justify its demands for a particular person. Weight loss within a fasting group cannot answer that question on its own: the change must be compared with the change in the control group.
02
What is being compared?
Intermittent fasting covers several schedules, and study protocols vary within each category. Some approaches restrict time, some restrict energy on selected days, and some combine both. Treating them as a single intervention can hide differences in what participants actually did.
| Approach | What changes |
|---|---|
| Time-restricted eating | Food is consumed within a daily time window; a calorie target may or may not also be prescribed. |
| Alternate-day fasting | Days of fasting or markedly reduced intake alternate with eating days. |
| Whole-day fasting, including 5:2 schedules | Selected days each week have no or substantially less energy intake. |
| Continuous calorie restriction | Energy intake is reduced each day without a required fasting schedule. |
Sources for this section: [2]
03
What the larger reviews found
A 2026 Cochrane review included 22 studies involving 1,995 adults. Compared with traditional dietary advice, intermittent fasting may make little or no difference to weight loss or quality of life. The evidence about adverse effects was uncertain. Follow-up extended to 12 months, so this review cannot establish what happens after many years.
A 2025 BMJ network meta-analysis covered 99 randomized trials with 6,582 adults. Alternate-day fasting was the only fasting strategy with a weight-loss advantage over continuous energy restriction in the overall comparison: about 1.29 kg more, with a 95% confidence interval of 0.59 to 1.99 kg more. The authors rated that estimate moderate certainty, but it was smaller than their 2 kg threshold for an important difference. Analyses of trials lasting at least 24 weeks did not establish an additional fasting advantage over continuous restriction.
These reviews used different eligibility rules and comparisons. Their study counts should not be added together, because trials can appear in both. Taken together, they support a cautious conclusion: fasting can be a workable strategy, but a large, sustained advantage over another weight-loss diet has not been demonstrated.
04
A 12-month trial puts the difference in context
In a 2022 randomized trial, 139 adults with obesity were assigned calorie restriction either with an 8 a.m. to 4 p.m. eating window or without a time restriction. At 12 months, average weight changes were −8.0 kg and −6.3 kg, respectively. Both groups lost weight; the question was the added value of the eating window.
The adjusted difference between groups was −1.8 kg, with a 95% confidence interval from −4.0 to +0.4 kg and a p-value of 0.11. That result did not establish an additional benefit from the time restriction. It also did not prove that the approaches are exactly equivalent: the interval still allowed a range of possible differences. Only 118 participants completed follow-up, another reason to read beyond the headline.
Read what a confidence interval does and does not establish
Sources for this section: [3]
05
Can people maintain it?
A schedule that seems simple on paper may fit one person's work and family meals but be difficult for another. The Cochrane review found no studies reporting participant satisfaction, so claims that fasting is universally easier are not justified. Short trials with substantial support also cannot fully represent an unsupported routine maintained for years.
Weight is only one outcome. Quality of life, nutrient intake, hunger, medication timing and the ability to maintain the approach matter too. These weight-loss trials do not establish that fasting extends human lifespan. A change in body weight or a metabolic marker is a different finding from preventing disease or helping people live longer.
06
Who needs particular caution?
Fasting can cause low blood glucose in people using insulin or some other glucose-lowering medicines. Anyone considering a major meal-timing change while using these treatments needs a plan with their diabetes clinician; medication doses should not be changed independently. Evidence from selected trial participants does not remove this risk.
Johns Hopkins guidance advises against intermittent fasting for children and teenagers, people who are pregnant or breastfeeding, and people with a history of eating disorders; it also highlights risk in type 1 diabetes treated with insulin. Persistent nausea, headaches or distress during a fasting schedule warrant medical advice. Limited reporting of harms in trials is not proof that every schedule is safe.
07
How to use this review
This is a focused narrative synthesis of selected recent systematic reviews, a directly relevant longer randomized trial, and official safety guidance, checked on September 8, 2026. Accessible full texts, publisher summaries and abstracts informed the review; it is not an exhaustive systematic search or a new pooled analysis. Paywalled full texts were not independently audited.
- Check which fasting schedule was tested and whether both groups received calorie targets.
- Look for the difference between groups, its uncertainty and the follow-up duration.
- Separate weight loss from claims about disease prevention or longevity.
- Discuss medication safety and whether the routine can fit ordinary life.
For readers choosing among approaches, the evidence supports making sustainability and safety central to the decision. It does not support promising that a particular fasting window will reliably outperform continuous calorie restriction for everyone.
Sources
- Garegnani et al. — Intermittent fasting for adults with overweight or obesityCochrane Database of Systematic Reviews · 2026Source accessed: DOI 10.1002/14651858.CD015610.pub2
- Semnani-Azad et al. — Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trialsBMJ · 2025Source accessed: DOI 10.1136/bmj-2024-082007
- Liu et al. — Calorie Restriction with or without Time-Restricted Eating in Weight LossNew England Journal of Medicine · 2022Source accessed: DOI 10.1056/NEJMoa2114833
- Low Blood Glucose (Hypoglycemia)National Institute of Diabetes and Digestive and Kidney DiseasesSource accessed:
- Intermittent Fasting: What is it, and how does it work?Johns Hopkins MedicineSource accessed:
Revision history
- Initial article prepared with automated assistance and sources checked at 2026-09-07T16:27:46Z (UTC). The publication timestamp 2026-09-05T11:07:35Z (UTC) was assigned retrospectively at the publisher's request; it is separate from preparation and source checking. This is a narrative evidence review. No independent clinical review is recorded. Date displays and this explanation use UTC; the recorded instants are unchanged.